14 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Medications: ... Agent, Initiation Dose ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... #Management #Pain ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Pharmacology # ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... #Pharmacology # ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... #Pharmacology # ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... - Agents and Dosing ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... site pain. --- ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
best prevented by using ... CD4 count >100 cells ... ., concomitant medications ... ) for 1–4 doses ... #HIVAIDS #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Indications: ... CD4 count ≥200 cells ... (Varivax™), 2 doses ... #HIVAIDS #pharmacology